Currently Enrolling
We are looking for subjects to test the safety and efficacy of an injection in potentially treating osteoarthritis (OA) of the knee. This study will look at how well an investigational study therapy works at addressing some of the symptoms of osteoarthritis (OA) of the knee.
Is this study right for me?
If you have inadequate pain relief from other treatments, please reach out to us in Napa at Neurovations Research.
If you qualify, you may also be invited to participate in a Long-Term Follow-up study of 15 years. If you choose not to participate in this study, you will be contacted once a year for 13 years to answer a questionnaire about your health.
You may qualify for the study if you meet the following requirements:
Are 40 years of age or older
Have OA symptoms of a certain severity
Note: additional criteria apply.
If accepted for this study, you will receive study-related medical care at no cost.
To see if you qualify, call Neurovations at 707-252-9606 or click on the link below to email us.
About Neurovations Research
Neurovations Research, founded in 2010, is at the forefront of innovation in the field of pain and neuromodulation. CEO and founder Dr. Eric Grigsby has led clinical trials with more than fifty companies, partnering with industry leaders and early-stage companies in medical device (Phase I-IV) and pharmaceutical trials (Phase II-IV), including first-in-man medical device trials, double-blinded and placebo-controlled trials.
What is osteoarthritis of the knee?
Osteoarthritis of the knee happens when cartilage in your knee joint breaks down. When this happens, the bones in your knee joint rub together, causing friction that makes your knees hurt, become stiff or swell.
To see if you qualify, call Neurovations at 707-252-9606 or click on the link below to email us.